Todays List of the Most Active Stock ( THLD, FBN, SRPT, COOL )

Los Angelas, CA -- (SBWIRE) -- 09/18/2012 -- Threshold Pharmac (NCM:THLD) reported EPS of -2.127. For the Current Fiscal year, the company is expected to report EPS of -2.08. For the Next Quarter and Next Year, the company is expected to repTHLDort EPS of -0.09 and -0.27 respectively. At Current Market Price, THLD is in distance of -10.89% from its 50-day Moving Average price of $7.8557 and -1.76% from its 200-day Moving Average price of $7.1251. Threshold Pharmaceuticals, Inc.(NASDAQ:THLD) shares plummeted 20.32% to $6.95 after the company's experimental pancreatic cancer drug didn't significantly improve patients' overall chance of survival. Patients treated with Threshold's TH-302 plus chemotherapy had a median survival of 9.2 months compared with 6.9 months for those treated with only chemotherapy in the second of what are typically three phases of clinical studies needed for regulatofry approval.

Should Investors Buy Or Hold THLD Now? Get Free Analysist Report

Furniture Brands (NYSE:FBN) is +0.06 - +3.80% from the previous close of $1.58. It traded between $1.55 - 1.82 with total traded volume of 1868967 shares. At Current Market Price, FBN is in distance of +49.40% from its 50-day Moving Average price of $1.0977 and +23.25% from its 200-day Moving Average price of $1.3306. Furniture Brands International Inc (NYSE:FBN) went up 10.13% to $1.74 on a traded volume of 651k shares. The 52-week range for the stock is $0.88 and $2.74. The Company has Price/Sales ratio of 0.08 and Price/Book ratio of 0.68. The 50-Day Moving Average and 200-Day Moving Average prices is $1.09 and $1.34 respectively. The Company is engaged in designing, manufacturing, sourcing and retailing home furnishings.

Should Investors Buy OR Hold FBN Now? Get Free Analysist Report

Sarepta Therapeut (NGM:SRPT) is +0.92 - +6.60% from the previous close of $13.93. It traded between $13.96 - 14.90 with total traded volume of 2195544 shares. Keep a close eye on SRPT, as the stock has been showing unusual moves over the past weeks. At Current market price, SRPT has recovered +395.00% from its 52-week Low of 3.00 and has Pulled back -9.67% from its 52-week high of 16.44. Sarepta Therapeutics (SRPT) is slated to announce key data on the company's Duchenne muscular dystrophy (DMD) drug candidate eteplirsen at the International Congress of the World Muscle Society in a late-breaker session on October 13. Recent favorable press, momentum from a string of positive results, and speculation about the possibility of accelerated approval have catapulted the stock from $4 to over $16 per share over the past several weeks. On Sept. 4, Sarepta announced a $40 million at-the-market equity offering; shares subsequently sold off to around $13.

Should Investors Buy OR Hold SRPT NOW? Get Free Analysist Report

Majesco Entertain (NCM:COOL) reported EPS of 0.084. For the Current Fiscal year, the company is expected to report EPS of 0.22. For the Next Quarter and Next Year, the company is expected to report EPS of 0.22 and 0.29 respectively. At Current Market Price, COOL is in distance of -19.87% from its 50-day Moving Average price of $1.6971 and -34.10% from its 200-day Moving Average price of $2.0638. Majesco Entertainment Co. (NASDAQ:COOL) is down 11.11% today at $1.36. COOL traded more than 5 times its average volume today with nearly 1.2 million shares traded. COOL have dropped 20% over the past three days following its earnings report. The company has a market cap of 54.25 million.

Should Investors Hold COOL Now? Get Free Analysist Report

Disclaimer:
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com